NAD+ therapy benefits
Pro Research Analysisby 
Searched over 200M research papers
NAD+ Therapy Benefits in Age-Related and Degenerative Diseases
NAD+ (nicotinamide adenine dinucleotide) is a vital molecule involved in energy production, DNA repair, gene expression, and cell signaling. Research shows that NAD+ levels decline with age and in many chronic diseases, making NAD+ therapy a promising strategy for improving health and treating age-related disorders 14.
NAD+ Therapy and Age-Related Disorders
Raising NAD+ levels through supplementation with precursors like nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), nicotinamide (NAM), and nicotinic acid (NA) has shown positive effects in preclinical and some clinical studies. These benefits include reduced oxidative stress, less inflammation, and improved mitochondrial function, which are all linked to healthier aging and reduced risk of degenerative diseases 14. However, while short-term safety appears favorable, more long-term human studies are needed to confirm these benefits and fully understand potential risks, such as toxic metabolite buildup or effects on tumor growth and cellular aging .
Cardiovascular and Metabolic Health Benefits
NAD+ therapy has demonstrated significant benefits in cardiovascular health. Supplementation or genetic interventions that increase NAD+ levels can improve heart function, reduce blood pressure, and protect against various forms of heart disease, including heart failure and cardiomyopathies, in animal models 358. These effects are largely due to improved mitochondrial function, better redox balance, and reduced protein hyperacetylation in heart cells 58. In metabolic diseases, such as nonalcoholic fatty liver disease (NAFLD), NAD+ therapy (especially with NR) has been shown to reduce liver fat, inflammation, insulin resistance, and fibrosis, partly by stimulating beneficial proteins like Fndc5/irisin .
Neurodegenerative Disease and Cognitive Function
NAD+ precursors, particularly NMN and NR, have shown promise in preclinical models of Alzheimer’s disease, improving cognitive function and reducing disease biomarkers. Early human trials with NR have also reported improvements in cognitive measures and neuroimaging biomarkers, suggesting potential for NAD+ therapy in neurodegenerative conditions, though more clinical research is needed .
NAD+ Therapy in Other Conditions and Natural Products
NAD+ metabolism is also a target for treating other conditions, including diabetes, skin disorders like psoriasis, and infections. Some natural products (such as certain phenols, flavonoids, and terpenoids) can boost NAD+ levels and have demonstrated antioxidant, anti-inflammatory, and anti-aging effects in preclinical studies, with good safety profiles 7910.
Safety and Future Directions
Most studies report that NAD+ precursors are safe and well-tolerated in the short term, but the long-term effects and optimal dosing strategies remain unclear. There is a need for more large-scale, well-designed clinical trials to determine the best ways to use NAD+ therapy, compare it to lifestyle interventions like exercise, and identify which patient groups will benefit most 17.
Conclusion
NAD+ therapy, especially through supplementation with precursors like NR and NMN, shows strong potential for improving health in aging, cardiovascular, metabolic, and neurodegenerative diseases. While preclinical and early clinical results are promising, more research is needed to confirm long-term safety and effectiveness in humans, and to optimize treatment strategies for different conditions 1345+5 MORE.
Sources and full results
Most relevant research papers on this topic